DXCM · NASDAQ · Medical - Devices

Dexcom

Builds continuous glucose monitors for diabetes care and broader metabolic-health tracking.

$90.77
After-hours close−0.05 (−0.06%)
At close$90.82(+1.71%)

Breakdown13F · Form 4

Institutions 113.41%Insiders 0.51%

A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.

Shares outstanding 377.36M · Float 376.05M · 99.7% free float

Top shareholders13F · 13D/G · Form 4

HolderShares% outstandingFormFiled
BlackRock, Inc.38.24M10.13%13FAug 7, 2026
Vanguard Capital Management LLC25.21M6.68%13FAug 13, 2026
Vanguard Portfolio Management LLC19.66M5.21%13FAug 13, 2026
State Street Corp18.38M4.87%13FAug 7, 2026
Invesco Ltd.15.29M4.05%13FAug 14, 2026

Institutions13F, as of Jun 30, 2026

1,020 holders · 427.97M shares · 125 new positions · 518 increased · 348 reduced · 116 closed

HolderShares% outstandingChg q/qFiled
BlackRock, Inc.38.24M10.13%−720.2KAug 7, 2026
Vanguard Capital Management LLC25.21M6.68%+188.8KAug 13, 2026
Vanguard Portfolio Management LLC19.66M5.21%+436.6KAug 13, 2026
State Street Corp18.38M4.87%+446.0KAug 7, 2026
Invesco Ltd.15.29M4.05%+7.21MAug 14, 2026
Baillie Gifford & Co14.80M3.92%−797.9KAug 6, 2026
Geode Capital Management, LLC12.43M3.29%+79.9KAug 12, 2026
AllianceBernstein L.P.11.69M3.10%−1.23MAug 14, 2026

Beneficial owners13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
BlackRock, Inc.8.30%32.50M13GApr 24, 2025
Vanguard Capital Management7.49%28.85M13GApr 29, 2026
Vanguard Portfolio Management5.02%19.32M13GApr 29, 2026

InsidersForm 4

InsiderRoleShares% outstandingFiled
Jacob Steven Leachdirector, officer: President, CEO, and Director418.9K0.11%Aug 25, 2026
Eric Topoldirector380.5K0.10%May 12, 2025
Kevin R. Sayerdirector, officer: Executive Chair302.2K0.08%Aug 24, 2026
Jereme M. Sylvainofficer: EVP, Chief Financal Officer150.4K0.04%Aug 25, 2026
Sadie Sternofficer: EVP Chief People & Culture Off126.0K0.03%Aug 28, 2026
Michael Jon Brownofficer: EVP Chief Legal Compliance Off101.5K0.03%Aug 25, 2026
Jon Colemanofficer: EVP, Chief Commercial Officer95.5K0.03%Jun 5, 2026
Steven R. Altmandirector69.2K0.02%Jun 1, 2026
Mark G. Folettadirector55.2K0.01%Aug 4, 2026
Richard Alexander Collinsdirector45.8K0.01%Jun 1, 2026

5 ten-percent owners hold 26.51M shares by Form 4, outside the officers-and-directors figure above · 30 people have not refiled in the last 18 months (4.17M shares), so they are not in the figure above

Latest trades

DateInsiderTypeSharesAvg priceOwned after
Aug 27, 2026
Sadie Sternofficer: EVP Chief People & Culture Off
Sale2,565$88.37126,043
Aug 20, 2026
Kevin R. Sayerdirector, officer: Executive Chair
Sale · 3 lots26,756$90.01302,214
Aug 14, 2026
Michael Jon Brownofficer: EVP Chief Legal Compliance Off
Sale1,700$91.93102,953
Aug 12, 2026
Bridgette P. Hellerdirector
Sale1,012$88.2929,570
Aug 3, 2026
Mark G. Folettadirector
Sale2,000$85.3248,852
Jul 31, 2026
Mark G. Folettadirector
Sale2,000$80.0050,852
Jul 20, 2026
Kevin R. Sayerdirector, officer: Executive Chair
Sale26,756$76.32328,970
Jul 15, 2026
Michael Jon Brownofficer: EVP Chief Legal Compliance Off
Sale1,700$74.42104,653
Jul 6, 2026
Kevin R. Sayerdirector, officer: Executive Chair
Sale26,756$72.00355,726
Jun 15, 2026
Mark G. Folettadirector
Sale · 2 lots4,000$74.1352,852

CongressHouse and Senate disclosures

MemberTypeAmountOwnerTradedDisclosed
Rep. Ro Khanna · CA17Purchase$1,001 – $15,000May 1, 2026Jun 11, 2026
Rep. Ro Khanna · CA17Purchase$1,001 – $15,000SpouseApr 13, 2026May 13, 2026
Sen. John Boozman · ARPurchase$1,001 – $15,000JointJan 26, 2026Feb 15, 2026
Sen. John Boozman · ARPurchase$1,001 – $15,000JointJan 26, 2026Feb 14, 2026